Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Himil Mahadevia"'
Autor:
Ujjwal Madan, Himil Mahadevia, Parth Sharma, Satya Preetham Gunta, Ossama Tawfik, Karen Fritchie, Julian Magadan
Publikováno v:
Autopsy and Case Reports, Vol 14 (2024)
Primary cardiac tumors are rare. The cardiac sarcomas are the most common malignant cardiac tumors. These tumors have a dismal prognosis with an overall median survival of 25 months. Clinical features include dyspnea, arrhythmias, pericardial effusio
Externí odkaz:
https://doaj.org/article/7182b069ac2f421ab1205a64e972085d
Autor:
Himil Mahadevia, Ben Ponvilawan, Ammar Al-Obaidi, Jennifer Buckley, Janakiraman Subramanian, Dhruv Bansal
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Immune checkpoint inhibitors (ICIs) and poly (ADP-ribose) polymerase (PARP) inhibitors have shown efficacy in various tumors. A significant therapeutic challenge with either ICIs or PARP inhibitors as monotherapy is treatment failure from intrinsic p
Externí odkaz:
https://doaj.org/article/4fb5286f5f1d46a8a961bf50d89e628a
Autor:
Himil Mahadevia, Lara Kujtan, Marc Roth, Parth Sharma, Jennifer R. Buckley, Eric Ewing, Dhruv Bansal
Publikováno v:
Case Reports in Oncology, Vol 16, Iss 1, Pp 784-790 (2023)
We present 2 cases of cancer of unknown origin in which RNA-based cancer classification testing provided vital insight and directed treatment management. The tissue of origin could not be determined in both of these patients utilizing morphology and
Externí odkaz:
https://doaj.org/article/76cbc76dfd104eeabe27d1e4e69b45f8
Publikováno v:
Haematologica, Vol 109, Iss 6 (2024)
Externí odkaz:
https://doaj.org/article/e02142a7679c40f58636e45e5b999cf5
Autor:
Omar Sh Ahmed, Himil Mahadevia, Rami Manochakian, Yujie Zhao, Manisha Salinas, Andras Khoor, Jordan LeGout, Yanyan Lou
Publikováno v:
Case Reports in Oncology, Vol 15, Iss 3, Pp 1063-1073 (2022)
Lung cancer is one of the most common cancers and has the highest risk of mortality in both genders. This devastating cancer is also a significant financial and emotional burden to patients and the healthcare system. Chemotherapy and immunotherapy ha
Externí odkaz:
https://doaj.org/article/845adbb410d34f3d96eb23d22cac0e10
Publikováno v:
Journal of the National Comprehensive Cancer Network. 21:CLO23-049
Autor:
Himil Mahadevia, Ben Ponvilawan, Parth Sharma, Ammar Al-Obaidi, Hana Qasim, Jagadish Koyi, Faiz Anwer, Shahzad Raza
Publikováno v:
Critical Reviews in Oncology/Hematology. 183:103917
Autor:
Tucker Coston, Himil Mahadevia, Marie M. Plante, Joseph M. Accurso, Akash Sharma, Geoffrey Johnson, Jonathan Ben Ashman, Ayse T. Kendi, Mohamad B. Sonbol, Timothy J. Hobday, Thorvardur Ragnar Halfdanarson, Jason S. Starr
Publikováno v:
Journal of Clinical Oncology. 41:641-641
641 Background: Tumors of neuroendocrine origin are a rare, heterogenous group of neoplasms. Neuroendocrine neoplasms (NENs) are categorized by site of origin, differentiation status, and by grade (Ki-67 expression and/or mitotic rate), with prognost
Publikováno v:
Journal of Clinical Oncology. 40:e16124-e16124
e16124 Background: Immune checkpoint inhibitors (ICI) have emerged as a standard treatment option for advanced hepatocellular carcinoma (HCC). Unfortunately, many patients with advanced HCC develop progressive disease on ICI therapy. Furthermore, cli